SCHEMBL14114476

SCHEMBL14114476

Fc1ccc(C2(c3[nH]nc(-c4ccccc4)c3C3CCCCC3)CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 5/20 0.37
▸ MAPK11 Q15759 4/20 0.37
▸ MAPK13 O15264 1/20 0.37
▸ RAF1 P04049 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ MAPK12 P53778 1/20 0.37
▸ MAP2K4 P45985 1/20 0.36
▸ ADORA1 P30542 4/20 0.36
▸ ADORA3 P0DMS8 3/20 0.36
▸ ADORA2A P29274 2/20 0.36
▸ SCN9A Q15858 1/20 0.35
▸ NPY5R Q15761 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KDM5B Q9UGL1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14114473 0.78 MAP2K4 (0.41) MAP2K4NPY5RATMNPSR1ALDH1A1
SCHEMBL14114471 0.75 MAP2K4 (0.39) MAP2K4NPY5RATMNPSR1ALDH1A1
SCHEMBL19941724 0.70 ALDH1A1 (0.44) RAF1ADORA1ADORA3ADORA2AATM
SCHEMBL19926124 0.70 ALDH1A1 (0.44) RAF1ADORA1ADORA3ADORA2AATM
SCHEMBL14114499 0.68 KDM4E (0.40) ALDH1A1KDM4EMAPT
SCHEMBL14114507 0.66 HTR7 (0.39) MAPK14NPY5RNPSR1ALDH1A1SMN1; SMN2
SCHEMBL14114503 0.66 KIT (0.37) MAPK14MAPK11MAPK13MAPK12ALDH1A1
SCHEMBL14114496 0.66 NPC1 (0.38) NPY5RNPSR1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL14114488 0.66 OPRL1 (0.33) —
SCHEMBL14114513 0.65 MAP2K4 (0.48) MAPK14MAPK11MAPK13MAPK12MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161374-A1 Pyrazole compounds and uses related thereto AMGEN INC. 2008-07-03 — — US disclosed
US-20080161374-A1 Pyrazole compounds and uses related thereto AMGEN INC. 2008-07-03 — — US disclosed
US-7354938-B2 Pyrazole compounds and uses related thereto AMGEN INC. (US) 2008-04-08 — — US disclosed
US-7354938-B2 Pyrazole compounds and uses related thereto AMGEN INC. (US) 2008-04-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161374-A1 Pyrazole compounds and uses related thereto GOT2, PC, ABAT MAPK14 1656/4885MAPK11 1448/4885MAPK13 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback